Fei Pan
Vermögen: 66 Mio $ am 31.05.2026
Vermögen: 66 Mio $ am 31.05.2026
Fei Pan is currently Chief Executive Officer & Executive Director at Jenscare Scientific Co., Ltd., a position starting in 2026.
Formerly, Mr. Pan was a Portfolio Manager at China International Capital Corp.
Ltd. (Invt Management).
Education includes a graduate degree from the University of Cambridge in 2010, a graduate degree from the University of Warwick in 2009, and an undergraduate degree from the University of Lancaster in 2008.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 13.05.2025 | 63’544’279 ( 20.48% ) | 66 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| JENSCARE SCIENTIFIC CO., LTD. | Vorstandsvorsitzender | 15.01.2025 |
| Unternehmen | Position | Ende |
|---|---|---|
China International Capital Corp. Ltd. (Invt Management)
China International Capital Corp. Ltd. (Invt Management) Investment ManagersFinance CICC-IM aims to deliver excellent, long-term performance through their proven investment process, established risk management framework and strong research capability. | Portfolio Manager-Aktien | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Lancaster
University of Lancaster Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Warwick
University of Warwick Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
China International Capital Corp. Ltd. (Invt Management)
China International Capital Corp. Ltd. (Invt Management) Investment ManagersFinance CICC-IM aims to deliver excellent, long-term performance through their proven investment process, established risk management framework and strong research capability. | Finance |
Jenscare Scientific Co. Ltd.
Jenscare Scientific Co. Ltd. Medical SpecialtiesHealth Technology Develops and sells transcatheter aortic valve systems | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen